Seidell and Bouchard
1 discuss the associations between visceral fat accumulation and obesity-related diseases, and conclude that it is dif®cult at present to be sure whether these are simply associations or whether there is causality involved. As these authors point out, the`visceral fat' hypothesis for obesityrelated diseases has gained rapid acceptance, although it is necessary to maintain a sceptical attitude until proof of causality is established.
When associations such as these are described, it is always easier to believe in causality when a plausible mechanism can be identi®ed. In this case, such a mechanism is not dif®cult to envisage. Many of the adverse metabolic consequences of obesity, could be mediated through increased delivery of non-esteri®ed fatty acids (NEFA) to the liver. These would include excessive VLDL-triacylglycerol secretion, stimulation of hepatic glucose production and impaired hepatic insulin clearance (hence, systemic hyperinsulinaemia). 2, 3 This makes a very attractive hypothesis, especially in the light of consistent demonstrations that`visceral fat' is more responsive to lipolytic stimuli in vitro than subcutaneous fat. 4 Recently this has been termed the`portal theory'. 3 However, following the warning from Seidell and Bouchard about the need for scepticism, we would like to offer the following thoughts about the portal theory. First, it is important to consider carefully, the idea that omental fat (whose lipolytic products are liberated into the portal vein) is more lipolytically active than subcutaneous fat. If this fat depot is consistently exporting fatty acids at a high rate, how is it supposed that it ever`accumulated' in the ®rst place? We believe that the only consistent interpretation is that this depot has a high rate of lipid turnover, with a high lipolytic capacity in times of stress or fasting, matched or exceeded at other times by a high capacity for fatty acid uptake and storage. Fatty acid uptake is likely to involve the lipoprotein lipase pathway. In that case, omental fat could be envisaged as protecting the liver from an in¯ux of triacylglycerol-fatty acids in the postprandial period. This emphasises the dif®culty of extrapolating from in vitro data on adipose tissue metabolism to in vivo situations.
Secondly, therefore, we suggest that is important to look critically at in vivo evidence for the`portal theory'. A direct test of this requires measurement of NEFA or glycerol concentrations in the hepatic portal vein. Such measurements have appeared from time to time in the literature. Hagenfeldt et al 5 took samples of hepatic portal blood at cholecystectomy in ®ve subjects. The mean arterial and portal vein NEFA concentrations were 561 and 580 mmol/l, respectively, and the authors concluded that the release of NEFA from omental adipose tissue was`of minor importance' (although surgical stress is one condition in which, on the above arguments, augmented omental lipolysis might be expected). Blackard et al 6 catheterised the hepatic portal vein via the umbilical vein, again at laparotomy in 14 subjects, and found arterial and portal venous NEFA concentrations of around 950 and 970± 990 mmol/l respectively (judged from the Figure 3 ). For comparison, in studies looking at the venous drainage from subcutaneous abdominal adipose tissue, typical NEFA concentrations after overnight fast are: arterial 595, adipose venous 1284 mmol/l, 7 although, of course, blood¯ow is less in subcutaneous adipose tissue, than through the portal vein. In addition, Bjo Èrkman et al 8 found portal and arterial concentrations of glycerol (another product of lipolysis) to be no different.
Further relevant information is provided by other, indirect studies. Haval et al 9 used albumin-bound 14 Clabelled palmitic acid infusion, to estimate extrahepatic splanchnic NEFA release (by dilution of the speci®c radioactivity in hepatic vein compared with brachial artery). The contribution of extra-hepatic splanchnic NEFA release (assumed to be from visceral adipose tissue) was found to be about 4.5% of total hepatic delivery of NEFA in normal subjects fasted overnight, although as high as 10% in hypertriglyceridaemic subjects (mean BMI 29.3 kg/m 2 ). Landau et al 10 performed similar studies with glycerol and concluded that`lipolysis in the mesentry accounts for only a small percentage of whole body lipolysis', although, of course, unlike lipolysis in other adipose tissue depots, its products are conveyed directly to the liver.
Such direct and indirect tests of the portal theory as are available are, therefore, far from conclusive. They do not obviously support the idea of a large additional in¯ux of fatty acids into the portal vein from visceral fat.
We conclude that Seidell and Bouchard 1 are absolutely correct to advocate scepticism about the visceral fat/obesity-related disease associations at present. Their suggestion of carefully controlled prospective studies is one way forward. We suggest that another, is to concentrate effort on proving or disproving the`portal hypothesis' in vivo. This will need dynamic measurements, direct or indirect, of NEFA release into the portal circulation, in different nutritional states.
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